EUVIMEDEUVIMED entdecken
Crossref

KMT2D upregulates SMG1 via histone methylation to antagonize mTOR and reinforce DLBCL ferroptosis

Yongcheng Sun iD, Zhijuan Xu, Zanzan Wang, Yanli Zhang, Ping Zhang, Lixia Sheng, Shujun Yang, Guifang Ouyang

Journal of Leukocyte Biology · 2025

DOI: 10.1093/jleuko/qiaf092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Yongcheng Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Ningbo University, No. 59 Liuting Street, Haishu District, Ningbo 315010, China. Hauptthemen laut MEDLINE: Ferroptosis, Lymphoma, Large B-Cell, Diffuse, Histones, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Ningbo Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse large B-cell lymphoma (DLBCL) is highly heterogeneous and prone to epigenetic mutations. Non-apoptotic cell death pathways, especially ferroptosis, have become an emerging direction for cancer treatment. This project was designed to probe into the potential of histone-lysine N-methyltransferase 2D (KMT2D) in modulating DLBCL ferroptosis through epigenetic mechanisms. We employed quantitative real-time polymerase chain reaction (qRT-PCR) and western blot (WB) to detect the expression level of KMT2D, CCK-8 assay to measure cell viability, flow cytometry to assess cell cycle and apoptosis, and fluorescent probes to analyze lipid reactive oxygen species levels. 4-hydroxynonaldehyde (4-HNE) and malondialdehyde were detected by WB and corresponding kits to determine the degree of intracellular ferroptosis. The level of H3K4Me1 was determined by using WB and immunofluorescence. Furthermore, we verified the transcriptional regulatory relationship between KMT2D and SMG1 through bioinformatics analysis, chromatin immunoprecipitation assay. We also applied WB to assess the activation of the AKT-mTOR pathway. Finally, the in vitro experimental results were validated by qRT-PCR, WB, immunohistochemistry, and fluorescent probe detection in a xenograft tumor model constructed in BALB/c nude mice. Overexpression of KMT2D considerably repressed the malignant behavior of DLBCL and triggered ferroptosis in cells. KMT2D was able to bind directly to the promoter region of the SMG1 gene and induce the transcriptional antagonistic mTOR pathway of SMG1 through H3K4Me1, thereby inducing ferroptosis in DLBCL cells. These findings demonstrate that KMT2D reinforces ferroptosis in DLBCL by antagonizing SMG1-mediated mTOR signaling, identifying it as a novel therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisLymphoma, Large B-Cell, DiffuseHistonesTOR Serine-Threonine KinasesUp-RegulationNeoplasm ProteinsHistone-Lysine N-MethyltransferaseHumansAnimalsMiceMethylationCell Line, TumorGene Expression Regulation, NeoplasticMice, NudeMice, Inbred BALB CSignal Transduction

Stichwörter der Autor:innen

SMG1diffuse large b-cell lymphomaferroptosishistone methylationhistone-lysine n-methyltransferase 2D

Substanzen

HistonesTOR Serine-Threonine KinasesMTOR protein, humanNeoplasm ProteinsHistone-Lysine N-Methyltransferase

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital of Ningbo University, No. 59 Liuting Street, Haishu District, Ningbo 315010, China.

ORCID-Profile: Yongcheng Sun

Förderung

  • Ningbo Science and Technology Bureau

Zitieren

APA

Sun, Y., Xu, Z., Wang, Z., Zhang, Y., Zhang, P., Sheng, L., Yang, S., & Ouyang, G. (2025). KMT2D upregulates SMG1 via histone methylation to antagonize mTOR and reinforce DLBCL ferroptosis. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiaf092

Vancouver

Sun Y, Xu Z, Wang Z, Zhang Y, Zhang P, Sheng L, et al. KMT2D upregulates SMG1 via histone methylation to antagonize mTOR and reinforce DLBCL ferroptosis. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiaf092

BibTeX
@article{Sun2025,
  author = {Sun, Yongcheng and Xu, Zhijuan and Wang, Zanzan and Zhang, Yanli and Zhang, Ping and Sheng, Lixia and Yang, Shujun and Ouyang, Guifang},
  title = {KMT2D upregulates SMG1 via histone methylation to antagonize mTOR and reinforce DLBCL ferroptosis},
  journal = {Journal of Leukocyte Biology},
  year = {2025},
  doi = {10.1093/jleuko/qiaf092}
}
Kostenlos starten →